Bridgebio Pharma Inc. (BBIO)

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Viking Global

Andreas Halvorsen

26,620,991 $270,203 1.09%
2.
Aristeia CapitalNOTE 2.500% 3/1

Robert Henry Lynch

100,224,000 $60,134 1.08%
3. 5,362,014 $54,424 1.13%
4.
Deerfield ManagementNOTE 2.500% 3/1

James E. Flynn

80,000,000 $47,402 1.05%
5.
Perceptive Advisors

Joseph Edelman

3,839,380 $38,969 -47% 0.78%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.39 12,000 Director 12,000 2022-03-15 Filing
$8.19 10,000 Director 20,000 2022-03-14 Filing
$15.91 5,000 Director 10,000 2022-01-05 Filing
$16.82 5,000 Director 5,000 2022-01-04 Filing
$14.48 17,600 Director 17,600 2021-12-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$12.80 11,745 Director 0 2021-12-28 Filing
$53.23 13,777 Officer, Director 45,860 2021-08-04 Filing
$60.47 3,450,000 31,060,971 2021-02-17 Filing
$69.94 8,563 Officer 12,568 2020-12-28 Filing
$69.34 10,937 Officer 21,131 2020-12-28 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 18,857,000 $10,823,918 0.01%
2. 246,948 $2,506,522 0%
3. 2,126,000 $1,026,005 0%
4. 65,459 $664,410 0%
5. 31,060,971 $315,269 2.85%
News See All